Our physicians remain committed to participating in ongoing retina research and providing our patients access to promising new treatment options through clinical trials. We recently opened four new clinical trials:

  • Diabetic Macular Edema: Oracle RZ402-201, Plano
  • Diabetic Retinopathy: Pavilla EYP-1901-204, Plano
  • Uveitis: Merkat GR44277, Dallas Main
  • Wet Macular Degeneration: COAST OPT-302-1005, Plano

Click here to access more detail about these new clinical trials along with 28 other studies we currently have open or underway for a variety of retina conditions.